KALA
Price:
$6.795
Market Cap:
$31.33M
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-07-20
Stock Exchange
NASDAQ
Ticker
KALA
According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.15. This represents a change of -45.49% compared to the average of 3.94 of the last 4 quarters.
The mean historical Current Ratio of Kala Pharmaceuticals, Inc. over the last ten years is 5.88. The current 2.15 Current Ratio has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), KALA's Current Ratio was at its highest in in the March 2018 quarter at 20.40. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
5.88
Median
6.33
Minimum
1.38
Maximum
10.41
Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 496.04%
Maximum Annual Current Ratio = 10.41
Minimum Annual Increase = -59.09%
Minimum Annual Current Ratio = 1.38
Year | Current Ratio | Change |
---|---|---|
2023 | 6.33 | 89.32% |
2022 | 3.35 | 0.68% |
2021 | 3.32 | -56.90% |
2020 | 7.71 | 81.10% |
2019 | 4.26 | -59.09% |
2018 | 10.41 | 30.60% |
2017 | 7.97 | -3.14% |
2016 | 8.23 | 496.04% |
The current Current Ratio of Kala Pharmaceuticals, Inc. (KALA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.33
5-year avg
4.99
10-year avg
5.88
Kala Pharmaceuticals, Inc.’s Current Ratio is less than Mallinckrodt plc (2.74), greater than Lifecore Biomedical, Inc. (1.83), greater than Lucy Scientific Discovery Inc. (0.38), less than Alimera Sciences, Inc. (2.79), greater than Adamis Pharmaceuticals Corporation (0.58), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Journey Medical Corporation (1.38), greater than Akanda Corp. (1.41), less than Organogenesis Holdings Inc. (3.09), greater than Biofrontera Inc. (1.53), less than Guardion Health Sciences, Inc. (16.67), greater than China Pharma Holdings, Inc. (0.00), less than Alkermes plc (3.45), less than Neurocrine Biosciences, Inc. (4.37), less than Intra-Cellular Therapies, Inc. (7.66), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Dynavax Technologies Corporation (13.23),
Company | Current Ratio | Market cap |
---|---|---|
2.74 | $4.52M | |
1.83 | $269.21M | |
0.38 | $906.91K | |
2.79 | $301.29M | |
0.58 | $7.25M | |
0.22 | $3.19M | |
1.38 | $112.18M | |
1.41 | $1.94M | |
3.09 | $536.94M | |
1.53 | $6.74M | |
16.67 | $4.35M | |
0.00 | $3.71M | |
3.45 | $4.66B | |
4.37 | $12.72B | |
7.66 | $9.08B | |
4.19 | $2.21B | |
13.23 | $1.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Kala Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Kala Pharmaceuticals, Inc. (KALA)?
What is the highest Current Ratio for Kala Pharmaceuticals, Inc. (KALA)?
What is the 3-year average Current Ratio for Kala Pharmaceuticals, Inc. (KALA)?
What is the 5-year average Current Ratio for Kala Pharmaceuticals, Inc. (KALA)?
How does the current Current Ratio for Kala Pharmaceuticals, Inc. (KALA) compare to its historical average?